Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Antimigraine Agents"'
Autor:
G. R. Tabeyeva
Publikováno v:
Медицинский совет, Vol 0, Iss 5, Pp 16-21 (2014)
The article highlights the issues of safety when using triptans in the treatment of migraine and the risks of cardiovascular complications. Results of a large prospective population study are provided demonstrating that triptans in patients with migr
Externí odkaz:
https://doaj.org/article/9e09cf23fb0742df928feedc13d81fdf
Publikováno v:
Drugs of today (Barcelona, Spain : 1998). 55(1)
Sixty-four new drugs and biologics reached their first global markets in 2018, the greatest number in at least a decade. In addition, 19 important new line extensions (new indications, new combinations or new formulations of previously marketed drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1e47e8c01ddbbcee872872f8309526e
https://pubmed.ncbi.nlm.nih.gov/30740611
https://pubmed.ncbi.nlm.nih.gov/30740611
Publikováno v:
Tropical Journal of Pharmaceutical Research; Vol 17, No 7 (2018); 1439-1444
Purpose : To determine the dispensing patterns of antimigraine agents in a private healthcare setting, focusing on seasonal variations in prescribing. Methods : A retrospective, cross-sectional drug utilization study was conducted using a South Afric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::370defcbe3daa7a89ba005e83ebe5834
https://doi.org/10.4314/tjpr.v17i7.30
https://doi.org/10.4314/tjpr.v17i7.30
Autor:
Rajan Mittal, Sushma Srivastava
Publikováno v:
Drug Screening Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::388d3a271c1fa11430f4f1c6a2d86c72
https://doi.org/10.5005/jp/books/12723_32
https://doi.org/10.5005/jp/books/12723_32
Publikováno v:
Current Vascular Pharmacology. 4:117-128
Migraine is characterized by attacks of intense pulsatile and throbbing headache, typically unilateral in nature with or without aura. Migraine affects a substantial fraction (10-20 %) of the world population (more women than men). With regard to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab99425cd6663830a3581f2c3228af27
https://doi.org/10.2174/157016106776359853
https://doi.org/10.2174/157016106776359853
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joseph P Yevich
Publikováno v:
Expert Opinion on Therapeutic Patents. 7:511-521
The patent literature pertaining to agents for the treatment of migraine headache and related disorders has been reviewed for the period of July 1, 1995 to December 31, 1996. Included are patents on serotonergic agents, such as 5-hydroxytryptamine 1D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bb9b01a2930dea85fa8d003d8ee0ac8
https://doi.org/10.1517/13543776.7.5.511
https://doi.org/10.1517/13543776.7.5.511
Autor:
Joseph P Yevich
Publikováno v:
Expert Opinion on Therapeutic Patents. 5:1077-1086
The patent literature pertaining to agents for the treatment of migraine headache and related disorders has been reviewed for the period of July 1, 1994 to June 30, 1995. Included are patents on serotonergic agents, i.e. 5-HT1D agonists, 5-HT2 recept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dfcfaddafdec7063dd67cb9c39137c0
https://doi.org/10.1517/13543776.5.10.1077
https://doi.org/10.1517/13543776.5.10.1077
Autor:
Richard Hargreaves, Christian Waeber
Publisher Summary This chapter discusses current and emerging strategies for migraine prevention and treatment in the light of the understanding of migraine pathophysiology. Discoveries in the field of migraine genetics, functional imaging, trigemino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f01c2b170292e368e2c26201030bdc0
https://doi.org/10.1016/s0072-9752(10)97065-6
https://doi.org/10.1016/s0072-9752(10)97065-6
Autor:
Audrey A.A. Fiddelers, Paul-Hugo M. van der Kuy, Marco A. E. Marcus, Nicole M.L. Veldhorst-Janssen, Cees Neef
Publikováno v:
Clinical therapeutics. 31(12)
Background: Interest in the development of drugdelivery devices that might improve treatment compliance is growing. A dosage formulation that is easy to use, such as intranasal application with transmucosal absorption, may offer advantages compared w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da9c4cfa6bf37fc53af2389498610ab8
https://pubmed.ncbi.nlm.nih.gov/20110035
https://pubmed.ncbi.nlm.nih.gov/20110035